Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 996,462 | 190,104 | -4,273 | 1,700,088 | 982,502 |
| Depreciation Amortization | 14,256 | 8,908 | 4,349 | 20,499 | 15,658 |
| Accounts receivable | -2,496 | -1,175 | 178 | -1,521 | -669 |
| Other Working Capital | 620,220 | 380,501 | 173,908 | 1,009,038 | 736,837 |
| Other Operating Activity | 398,019 | 744,509 | 490,476 | 259,698 | 480,846 |
| Operating Cash Flow | $2,026,461 | $1,322,847 | $664,638 | $2,987,802 | $2,215,174 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -18,000 | -18,000 | N/A | -2,115,522 | N/A |
| PPE Investments | -2,009,283 | -814,712 | -86,084 | N/A | -1,113,283 |
| Purchase Of Investment | -273,455 | -260,955 | -6,971 | -24,942 | -22,950 |
| Sale Of Investment | 126,172 | 111,803 | 6,405 | 69,713 | 63,616 |
| Other Investing Activity | 2,039 | 2,038 | 0 | -2,038 | 0 |
| Investing Cash Flow | $-2,172,527 | $-979,826 | $-86,650 | $-2,072,789 | $-1,072,617 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 350,000 | N/A |
| Debt Issued | 1,471,235 | 1,471,235 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | -1,000,000 | -1,000,000 |
| Common Stock Issued | 3,856 | 2,596 | 1,426 | 7,476 | 6,370 |
| Common Stock Repurchased | -177,044 | -79,999 | N/A | -304,759 | -274,559 |
| Dividend Paid | -657,598 | -430,964 | -213,424 | -854,848 | -648,671 |
| Other Financing Activity | -21,341 | -18,255 | 0 | -346,623 | 0 |
| Financing Cash Flow | $619,108 | $944,613 | $-211,998 | $-2,148,754 | $-1,916,860 |
| Beginning Cash Position | 477,010 | 477,010 | 477,010 | 1,710,751 | 1,710,751 |
| End Cash Position | 950,052 | 1,764,644 | 843,000 | 477,010 | 936,448 |
| Net Cash Flow | $473,042 | $1,287,634 | $365,990 | $-1,233,741 | $-774,303 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,026,461 | 1,322,847 | 664,638 | 2,987,802 | 2,215,174 |
| Capital Expenditure | -2,009,283 | -814,712 | -86,084 | N/A | -1,113,283 |
| Free Cash Flow | 17,178 | 508,135 | 578,554 | 2,987,802 | 1,101,891 |